Trials / Completed
CompletedNCT01138683
Cardiorenal Interactions During Treatment of Acute Decompensated Heart Failure: Diuretics Versus Ultrafiltration
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- University Hospital, Ghent · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The CRUF trial is a prospective randomized monocentric trial comparing different impact of diuretics versus ultrafiltration on renal congestion, plasma refill rate, echocardiographic filling pressures, neurohormonal activation and biomarkers of Acute Kidney Injury (AKI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ultrafiltration | Ultrafiltration through double lumen catheter, via central vein (Vena jugularis interna or Vena femoralis, 11 French, 15 cm for right jugular or 20 cm for femoralis and jugularis left-position). Based on severity of fluid overload the cardiologist determines the ultrafiltration rate. 'Multifiltrate Fresenius' (extracorporeal blood volume 72ml) in SCUF (slow continuous ultrafiltration) modus with pediatric lines (54 ml extracorporeal volume in the AV-set) and a pediatric filter (Ultraflux® AV paed, blood volume 18ml). Heparin to maintain an APTT between 65 en 85 seconds during ultrafiltration. |
| DRUG | diuretics | Bumetanide continuous infusion to reach a prescribed negative fluid balance: dose adjustment according to the diuretic response. |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2011-10-01
- Completion
- 2011-12-01
- First posted
- 2010-06-07
- Last updated
- 2012-01-10
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01138683. Inclusion in this directory is not an endorsement.